168 related articles for article (PubMed ID: 31666638)
1. UGCG influences glutamine metabolism of breast cancer cells.
Schömel N; Hancock SE; Gruber L; Olzomer EM; Byrne FL; Shah D; Hoehn KL; Turner N; Grösch S; Geisslinger G; Wegner MS
Sci Rep; 2019 Oct; 9(1):15665. PubMed ID: 31666638
[TBL] [Abstract][Full Text] [Related]
2. UGCG overexpression leads to increased glycolysis and increased oxidative phosphorylation of breast cancer cells.
Schömel N; Gruber L; Alexopoulos SJ; Trautmann S; Olzomer EM; Byrne FL; Hoehn KL; Gurke R; Thomas D; Ferreirós N; Geisslinger G; Wegner MS
Sci Rep; 2020 May; 10(1):8182. PubMed ID: 32424263
[TBL] [Abstract][Full Text] [Related]
3. UDP-glucose ceramide glucosyltransferase activates AKT, promoted proliferation, and doxorubicin resistance in breast cancer cells.
Wegner MS; Schömel N; Gruber L; Örtel SB; Kjellberg MA; Mattjus P; Kurz J; Trautmann S; Peng B; Wegner M; Kaulich M; Ahrends R; Geisslinger G; Grösch S
Cell Mol Life Sci; 2018 Sep; 75(18):3393-3410. PubMed ID: 29549423
[TBL] [Abstract][Full Text] [Related]
4. The UDP-glucose ceramide glycosyltransferase (UGCG) and the link to multidrug resistance protein 1 (MDR1).
Wegner MS; Gruber L; Mattjus P; Geisslinger G; Grösch S
BMC Cancer; 2018 Feb; 18(1):153. PubMed ID: 29409484
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of glycosphingolipid biosynthesis reverts multidrug resistance by differentially modulating ABC transporters in chronic myeloid leukemias.
Salustiano EJ; da Costa KM; Freire-de-Lima L; Mendonça-Previato L; Previato JO
J Biol Chem; 2020 May; 295(19):6457-6471. PubMed ID: 32229586
[TBL] [Abstract][Full Text] [Related]
6. Increased glucosylceramide production leads to decreased cell energy metabolism and lowered tumor marker expression in non-cancerous liver cells.
Wegner MS; Schömel N; Olzomer EM; Trautmann S; Olesch C; Byrne FL; Brüne B; Gurke R; Ferreirós N; Weigert A; Geisslinger G; Hoehn KL
Cell Mol Life Sci; 2021 Nov; 78(21-22):7025-7041. PubMed ID: 34626204
[TBL] [Abstract][Full Text] [Related]
7. Increased ceramide production sensitizes breast cancer cell response to chemotherapy.
Che J; Huang Y; Xu C; Zhang P
Cancer Chemother Pharmacol; 2017 May; 79(5):933-941. PubMed ID: 28357533
[TBL] [Abstract][Full Text] [Related]
8. The sirtuin inhibitor cambinol reduces intracellular glucosylceramide with ceramide accumulation by inhibiting glucosylceramide synthase.
Ishibashi Y; Ito M; Hirabayashi Y
Biosci Biotechnol Biochem; 2020 Nov; 84(11):2264-2272. PubMed ID: 32705968
[TBL] [Abstract][Full Text] [Related]
9. A sensitive method for determining UDP-glucose: ceramide glucosyltransferase (UGCG) activity in biological samples using deuterated glucosylceramide as acceptor substrate.
Cas MD; Casati S; Roda G; Pablo Sardi S; Paroni R; di Fonzo A; Trinchera M
Glycobiology; 2023 Mar; 33(2):88-94. PubMed ID: 36504340
[TBL] [Abstract][Full Text] [Related]
10. Ceramide glucosyltransferase of the nematode Caenorhabditis elegans is involved in oocyte formation and in early embryonic cell division.
Nomura KH; Murata D; Hayashi Y; Dejima K; Mizuguchi S; Kage-Nakadai E; Gengyo-Ando K; Mitani S; Hirabayashi Y; Ito M; Nomura K
Glycobiology; 2011 Jun; 21(6):834-48. PubMed ID: 21325339
[TBL] [Abstract][Full Text] [Related]
11. Regulation of glucosylceramide synthesis by Golgi-localized phosphoinositide.
Ishibashi Y; Ito M; Hirabayashi Y
Biochem Biophys Res Commun; 2018 May; 499(4):1011-1018. PubMed ID: 29627573
[TBL] [Abstract][Full Text] [Related]
12. Glucose availability and glycolytic metabolism dictate glycosphingolipid levels.
Stathem M; Marimuthu S; O'Neal J; Rathmell JC; Chesney JA; Beverly LJ; Siskind LJ
J Cell Biochem; 2015 Jan; 116(1):67-80. PubMed ID: 25145677
[TBL] [Abstract][Full Text] [Related]
13. Hepatic glycosphingolipid deficiency and liver function in mice.
Jennemann R; Rothermel U; Wang S; Sandhoff R; Kaden S; Out R; van Berkel TJ; Aerts JM; Ghauharali K; Sticht C; Gröne HJ
Hepatology; 2010 May; 51(5):1799-809. PubMed ID: 20432257
[TBL] [Abstract][Full Text] [Related]
14. Update on Glycosphingolipids Abundance in Hepatocellular Carcinoma.
Byrne FL; Olzomer EM; Lolies N; Hoehn KL; Wegner MS
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562868
[TBL] [Abstract][Full Text] [Related]
15. Glucosylceramide synthase regulates the proliferation and apoptosis of liver cells in vitro by Bcl‑2/Bax pathway.
Li JF; Zheng SJ; Wang LL; Liu S; Ren F; Chen Y; Bai L; Liu M; Duan ZP
Mol Med Rep; 2017 Nov; 16(5):7355-7360. PubMed ID: 28944894
[TBL] [Abstract][Full Text] [Related]
16. DNA damage induces down-regulation of UDP-glucose ceramide glucosyltransferase, increases ceramide levels and triggers apoptosis in p53-deficient cancer cells.
Haynes TA; Filippov V; Filippova M; Yang J; Zhang K; Duerksen-Hughes PJ
Biochim Biophys Acta; 2012 Jul; 1821(7):943-53. PubMed ID: 22349266
[TBL] [Abstract][Full Text] [Related]
17. Regulation of sphingolipid and glycosphingolipid metabolism in extrahepatic tissues by endotoxin.
Memon RA; Holleran WM; Uchida Y; Moser AH; Grunfeld C; Feingold KR
J Lipid Res; 2001 Mar; 42(3):452-9. PubMed ID: 11254758
[TBL] [Abstract][Full Text] [Related]
18. MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer.
Shajahan-Haq AN; Cook KL; Schwartz-Roberts JL; Eltayeb AE; Demas DM; Warri AM; Facey CO; Hilakivi-Clarke LA; Clarke R
Mol Cancer; 2014 Oct; 13():239. PubMed ID: 25339305
[TBL] [Abstract][Full Text] [Related]
19. Influence of glycosphingolipids on cancer cell energy metabolism.
Schömel N; Geisslinger G; Wegner MS
Prog Lipid Res; 2020 Jul; 79():101050. PubMed ID: 32592726
[TBL] [Abstract][Full Text] [Related]
20. [Cell-specific deletion of glucosylceramide synthase in brain leads to severe neural defects after birth].
Jennemann R; Sandhoff R; Wiegandt H; Gröne HJ
Verh Dtsch Ges Pathol; 2006; 90():193-202. PubMed ID: 17867597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
